Recently, high dimensional mapping of tumour-infiltrating lymphocytes (TILs) using 36 colour Cytof revealed that cancer vaccines can induce the expression of NKG2A on a population of CD103+ effector CD8+ T cells. The gene discussed is KLRC1; the disease is cancer.